ArticleScientific reports2025
Minimally overlapping technique of bioresorbable scaffolds in a porcine coronary artery model: proof-of-concept study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanically Robust Biodegradable Stents With Theragenerative Vascular Responses via Combined 3D Printing and Janus Nanoengineering.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Overlapping stent placement is a common approach for treating long coronary artery disease, but is associated with increased risks of restenosis and thrombosis. This preliminary study evaluated the efficacy and safety of a minimally overlapping technique using bioresorbable scaffolds (BRSs) compared with the conventional overlapping technique in a porcine coronary artery model. Eight coronary arteries were randomly assigned to two groups. In the overlapping group, two BRSs overlapped by 2.4 mm. In the end-to-end group, both ends of the BRSs were minimally overlapped, guided by balloon and scaffold markers. Lesions were assessed through phantom study, coronary angiography, optical coherence tomography, and histological analysis. Technical success was achieved in both groups. Strut fractures were observed in the overlapping group but not in the end-to-end group. BRS-induced neointimal tissue formation related variables were significantly lower in the end-to-end group (all p < 0.001). Apoptotic cells were significantly reduced in the end-to-end group compared with the conventional overlapping group (p < 0.001). The minimally overlapping technique using BRSs effectively maintained luminal patency and structural integrity for 4 weeks, suggesting that the end-to-end method may be a favorable strategy for treating long diffuse coronary lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.